Local view for "http://purl.org/linkedpolitics/eu/plenary/2003-06-05-Speech-4-026"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20030605.1.4-026"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Mr President, I would like to extend a greeting, like you, to those of our male colleagues who are in the Chamber because, as Mr Mussa said, the disease in question does indeed affect men as well. When it affects us, it affects our spouses, families and children. Moreover, the psychological climate surrounding this disease is not without impact on the lives of those around us.
Although, as the rapporteur stresses, it is difficult to compare the available data in the absence of uniform standards, they do show that breast cancer incidence fluctuates from one country of the European Union to another. As already mentioned, then, the disease is one of the main causes of death for women between the ages of 35 and 55, which is why it is essential to define early detection and overall care of patients as European priorities.
That is what Mrs Jöns’ report makes clear to us. It recommends the implementation of detection campaigns carried out in multidisciplinary clinics (this is very, very important), providing medical care if necessary, of course, but also psychological and social care, delivered before and after treatment by highly-trained staff. This can sometimes be another great asset in treating the illness.
In France, a cancer steering committee published a report in January 2003, which has very recently allowed the President of the Republic to draw up a national plan for an anti-cancer campaign. The French report bears remarkable similarities to your own, in terms both of its findings and the objectives it proposes.
Taking into account the physical and psychological stress caused by breast cancer treatments, and in order to ensure the best possible quality of life for women, it is essential to act pre-emptively, through suitable information and prevention policies, to encourage women of all ages to undergo regular screening.
For this reason, we can only agree that there is a need to coordinate national policies, pursue the development of European mammography guidelines, intensify research, review the problem of gene patenting by the European Patents Office and establish registers other than the national ones currently in existence.
Mrs Jöns’ report, as adopted by the Committee on Women’s Rights and Equal Opportunities, seems to respond to these objectives. That is why the Group of the European People’s Party (Christian Democrats) and European Democrats has decided to vote for the motion, for I have to say that it shows a certain amount of courage. Furthermore, since we are lucky enough to have a woman Commissioner here today, and since we know that the fifth framework programme has set aside EUR 400 million, why not make cancer a major priority in Europe from 2004, Commissioner?
That would be a proactive response to Mrs Jöns’ call for a conference."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples